Skip to main content

Table 2 Meta-analysis of studies included conducted on the prevalence of HTN

From: Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression

HTNNumber of observationsI2aPublication biasPooled Prevalence (95%CI)
All studies
 Reproductive age52990.5670.11 (0.10, 0.12)
  Case26990.4590.15 (0.12, 0.18)
  Control26990.8670.09 (0.08, 0.10)
 Menopause/ aging12950.4980.44 (0.32, 0.56)
  Case6650.5040.49 (0.28, 0.70)
  Control6970.2590.40 (0.22, 0.57)
Population based studies
 Reproductive age28990.7680.09 (0.08, 0.11)
  Case14990.3430.12 (0.08, 0.15)
  Control14990.2180.08 (0.06, 0.09)
 Menopause/ aging4940.2500.50 (0.33, 0.68)
  Case20.3170.60 (0.52, 0.68)
  Control20.3170.44 (0.40, 0.48)
Non-Population based studies
 Reproductive age24930.7680.16 (0.12, 0.19)
  Case12940.9870.20 (0.14, 0.26)
  Control12940.8000.12 (0.08, 0.16)
 Menopause/ aging8930.3280.41 (0.26, 0.55)
  Case4970.2500.47 (0.21, 0.73)
  Control4950.2430.35 (0.11, 0.59)
  1. I2 I-squared
  2. a assessed by Begg’s test